Taking the advantages of new drug delivery system to accelerate the development of Chinese pharmaceutic industry / 国际药学研究杂志

ABSTRACT

New drug research and development has entered a new era of preparation innovation, and new drug delivery system (DDS) has become a new drug development hot spot. Chinese pharmaceutical industry should make new molecular entities (NME) and new formulation products as the two pillars of support to ensure a sustained and healthy development. Based on the current status of the Chinese pharmaceutical industry, NME development is more suitable to serve as long term strategy of the Chinese pharmaceutical industry, while the nnovation in DDS should be adopted as a phasic development strategy. DDS can form the competitive strength, industrial superiority and scale more quickly and will become a catalyst and driving force in a short time for the Chinese pharmaceutical industry. Chinese pharmaceutical enterprises need to attach importance to and grasp the new opportunities brought by innovation preparation.